{"id":"https://openalex.org/A5116045526","orcid":null,"observed_orcids":[],"display_name":"Primrose Nakazibwe","raw_author_names":["Primrose Nakazibwe"],"full_name":"Primrose Nakazibwe","works_count":2,"cited_by_count":2,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5116045526","orcid":null,"observed_orcids":[]},"affiliations":[{"institution":{"id":"https://openalex.org/I3132131080","ror":"https://ror.org/00nmq1179","display_name":"Ndejje University","country_code":"UG","type":"education","lineage":["https://openalex.org/I3132131080"]},"years":[2026,2024]}],"last_known_institutions":[{"id":"https://openalex.org/I3132131080","ror":"https://ror.org/00nmq1179","display_name":"Ndejje University","country_code":"UG","type":"education","lineage":["https://openalex.org/I3132131080"]}],"topics":[{"id":"https://openalex.org/T10227","display_name":"Acute Ischemic Stroke Management","count":1,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","count":1,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11446","display_name":"Mobile Health and mHealth Applications","count":1,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","count":1,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13194","display_name":"ICT in Developing Communities","count":1,"subfield":{"id":"https://openalex.org/subfields/1710","display_name":"Information Systems"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"topic_share":[{"id":"https://openalex.org/T13945","display_name":"Legal, Health, Environmental and COVID-19 Challenges","value":1.34e-05,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13194","display_name":"ICT in Developing Communities","value":1.03e-05,"subfield":{"id":"https://openalex.org/subfields/1710","display_name":"Information Systems"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T11446","display_name":"Mobile Health and mHealth Applications","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/3600","display_name":"General Health Professions"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10833","display_name":"Vaccine Coverage and Hesitancy","value":4.3e-06,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","value":4e-06,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"x_concepts":[{"id":"144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","score":0.7131999731063843},{"id":"112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","score":0.4146000146865845},{"id":"127454912","wikidata":"https://www.wikidata.org/wiki/Q942582","display_name":"Cost\u2013benefit analysis","score":0.3402999937534332},{"id":"138816342","wikidata":"https://www.wikidata.org/wiki/Q189603","display_name":"Public health","score":0.27970001101493835},{"id":"127413603","wikidata":"https://www.wikidata.org/wiki/Q11023","display_name":"Engineering","score":0.2515970468521118}],"counts_by_year":[{"year":2024,"works_count":1,"oa_works_count":1,"cited_by_count":0},{"year":2026,"works_count":1,"oa_works_count":1,"cited_by_count":2}],"display_name_alternatives":["Primrose Nakazibwe"],"block_key":"p nakazibwe","works_api_url":"https://api.openalex.org/works?filter=author.id:A5116045526","awards_count":0,"updated_date":"2026-11-07T12:08:38","created_date":"2024-12-19T00:00:00"}